WILLIAM WELLER: Open Payments
NPI 1326799594 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 10 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $0 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: AIRSUPRA, GEMTESA, TRELEGY ELLIPTA, Leqembi, Kerendia, CAPLYTA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
